Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

6MP5

Crystal structure of native human sulfide:quinone oxidoreductase

Summary for 6MP5
Entry DOI10.2210/pdb6mp5/pdb
DescriptorSulfide:quinone oxidoreductase, mitochondrial, FLAVIN-ADENINE DINUCLEOTIDE (3 entities in total)
Functional Keywordssulfide:quinone oxidoreductase, rossman fold, hydrogen sulfide metabolism, thiocystine, membrane protein, oxidoreductase
Biological sourceHomo sapiens (Human)
Total number of polymer chains4
Total formula weight188403.03
Authors
Jackson, M.R.,Jorns, M.S.,Loll, P.J. (deposition date: 2018-10-05, release date: 2019-04-10, Last modification date: 2024-10-16)
Primary citationJackson, M.R.,Loll, P.J.,Jorns, M.S.
X-Ray Structure of Human Sulfide:Quinone Oxidoreductase: Insights into the Mechanism of Mitochondrial Hydrogen Sulfide Oxidation.
Structure, 27:794-805.e4, 2019
Cited by
PubMed Abstract: Hydrogen sulfide (HS) is a gasotransmitter exhibiting pivotal functions in diverse biological processes, including activation of multiple cardioprotective pathways. Sulfide:quinone oxidoreductase (SQOR) is an integral membrane flavoprotein that catalyzes the first step in the mitochondrial metabolism of HS. As such, it plays a critical role in controlling physiological levels of the gasotransmitter and has attracted keen interest as a potential drug target. We report the crystal structure of human SQOR, unraveling the molecular basis for the enzyme's ability to catalyze sulfane sulfur transfer reactions with structurally diverse acceptors. We demonstrate that human SQOR contains unique features: an electropositive surface depression implicated as a binding site for sulfane sulfur acceptors and postulated to funnel negatively charged substrates to a hydrophilic HS-oxidizing active site, which is connected to a hydrophobic internal tunnel that binds coenzyme Q. These findings support a proposed model for catalysis and open the door for structure-based drug design.
PubMed: 30905673
DOI: 10.1016/j.str.2019.03.002
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (2.99 Å)
Structure validation

236060

PDB entries from 2025-05-14

PDB statisticsPDBj update infoContact PDBjnumon